Design and conduct of early-phase radiotherapy trials with targeted therapeutics: Lessons from the PRAVO experience
Author:
Funder
Akershus University Hospital
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference122 articles.
1. Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability;Lai;Int J Radiat Oncol Biol Phys,2008
2. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme;Lai;J Clin Oncol,2011
3. The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma;Vredenburgh;Clin Cancer Res,2011
4. Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme;Vredenburgh;Int J Radiat Oncol Biol Phys,2012
5. A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma;Narayana;J Neurosurg,2012
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations—CONCORDE;JCO Precision Oncology;2022-11
2. A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations;Clinical Cancer Research;2022-05-12
3. Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib;BMC Cancer;2019-09-10
4. Local Radiotherapy Affects Drug Pharmacokinetics—Exploration of a Neglected but Significant Uncertainty of Cancer Therapy;Technology in Cancer Research & Treatment;2017-10-31
5. Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy;Cancer Research and Treatment;2017-04-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3